Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1996-01-25
1997-08-05
Henley, III, Raymond
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
A61K 3124
Patent
active
056543344
ABSTRACT:
N-L-.alpha.-aspartyl-L-phenylalanine 1-methyl ester and/or its derivatives has been found to have analgesic pain relieving properties. It has been found to be especially effective in relieving pain associated with osteoarthritis and multiple sclerosis. It can be administered by itself or in combination with other analgesics. When given in combination with other analgesics, N-L-.alpha.-aspartyl-L-phenylalanine 1-methyl ester and/or its derivatives helps to alleviate the detrimental side effects of other analgesic medications by lowering the dosage requirements for pain relief.
REFERENCES:
patent: 3492131 (1970-01-01), Schlatter
patent: 4689218 (1987-08-01), Gazzaniga et al.
patent: 5053393 (1991-10-01), Tjoeng
patent: 5053396 (1991-10-01), Blass
patent: 5496856 (1996-03-01), Creppy
Leon et al., "Safety of Long-term Large Doses of Aspartame", Archives of Internal Medicine, 149, pp. 2318-2324 1989.
Douglas, W.W., "Polypeptides-angiotensin, plasma kinins, and other vasoactive agents; prostaglandins," The Pharmacological Basis of Therapeutics, 5th ed., L. S. Goodman and A. Gilman (eds.), MacMillan Publishing Co., Inc., New York, p. 647 (1975).
Guiso, et al., "Effect of tyrosine on the potentiation by aspartame and phenylalanine of metrazol-induced convulsions in rats," Fd Chem Toxic 29:855-857 (1991).
Insel, Paul, "Analgesic-antipyretic and antiinflammatory agents and drugs employed in the treatment of gout," The Pharmacological Basis of Therapeutics, 9th ed., J. G. Hardman and L.E. Limbird (eds.), McGraw-Hill Companies, Inc., New York, pp. 620-622 (1996).
Picot, et al., "The x-ray crystal structure of the membrane protein prostaglandin H.sub.2 synthase-1," Nature 367:243-249 (1991).
Edmundson Allen B.
Manion Carl V.
Henley III Raymond
Oklahoma Medical Research Foundation
LandOfFree
Analgesic use of N-L-.alpha.-aspartyl-L-phenylalanine 1-methyl e does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Analgesic use of N-L-.alpha.-aspartyl-L-phenylalanine 1-methyl e, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Analgesic use of N-L-.alpha.-aspartyl-L-phenylalanine 1-methyl e will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1075207